SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE430.400.65 (+0.15 %)
PREV CLOSE ( ) 429.75
OPEN PRICE ( ) 431.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 430.40 (269)
VOLUME 286596
TODAY'S LOW / HIGH ( )428.00 436.80
52 WK LOW / HIGH ( )375.4 678.8
NSE430.500.8 (+0.19 %)
PREV CLOSE( ) 429.70
OPEN PRICE ( ) 431.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 430.50 (12412)
VOLUME 4373261
TODAY'S LOW / HIGH( ) 428.45 436.75
52 WK LOW / HIGH ( )370.2 679.3
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
13Feb Sun Pharma reports around 4-fold jump
Sun Pharmaceutical Industries has reported results for third quarter end..
13Feb Sun Pharma shines on reporting around
Sun Pharmaceutical Industries is currently trading at Rs. 448.75, up by..
04Feb Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the exchange has receive..
22Jan Sun Pharma to replace domestic formula
Sun Pharmaceutical Industries is going to replace its domestic formulati..
22Jan Sun Pharma trades higher on the BSE
Sun Pharmaceutical Industries is currently trading at Rs. 417.15, up by..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit-386.8-4945.9
Gross Profit -650.7 -5199.8
Operating Profit 2023.712510.6
Net Sales 22612.679476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 2998.60 (2.37%)
M.Cap (Rs. in Cr)13717.91
Piramal Enterprises (BSE)
 2302.20 (2.77%)
M.Cap (Rs. in Cr)42369.73
Dr. Reddys Lab (BSE)
 2637.40 (2.01%)
M.Cap (Rs. in Cr)43796.89
Coral Laboratories (BSE)
 319.60 (6.64%)
M.Cap (Rs. in Cr)114.18
Astrazeneca Pharma I (BSE)
 1871.00 (0.90%)
M.Cap (Rs. in Cr)4677.50
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 13.09%
MUTUAL FUNDS/UTI 9.69%
FI/BANKS/INSURANCE 7.8%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.